FDA 483 - Aventura Fertility & IVF - March 10, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Aventura Fertility & IVF in Aventura, FL, identified significant issues with donor eligibility determination and screening for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The firm failed to properly document reasons for donor ineligibility, adequately screen donors for communicable disease risks, and establish compliant procedures for donor eligibility. These deficiencies indicate a lack of robust controls over critical aspects of donor screening and record-keeping.
ID · 6f5c5956-8e2c-4096-9863-14e4fdd90043